טוען...
Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction.
We have studied the pharmacokinetics of 1-g intravenous doses of aztreonam in four groups of six volunteers each, distinguished by their creatinine clearances (greater than 80, 30 to 80, 10 to 29, and less than 10 ml/min). Subjects received 1 g of aztreonam intravenously without any complications. A...
שמור ב:
Main Authors: | , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
1983
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC185147/ https://ncbi.nlm.nih.gov/pubmed/6685452 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|